OMERS ADMINISTRATION Corp Purchases New Position in CME Group Inc. $CME

OMERS ADMINISTRATION Corp purchased a new position in CME Group Inc. (NASDAQ:CMEFree Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 23,789 shares of the financial services provider’s stock, valued at approximately $5,253,000.

Other large investors also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC raised its position in CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the period. Elkhorn Partners Limited Partnership purchased a new position in shares of CME Group in the 4th quarter worth approximately $27,000. Hilton Head Capital Partners LLC purchased a new position in shares of CME Group in the 4th quarter worth approximately $28,000. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of CME Group in the 2nd quarter worth approximately $28,000. Finally, Legacy Wealth Managment LLC ID increased its position in shares of CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard bought 325 shares of CME Group stock in a transaction on Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent research reports. Rothschild & Co Redburn upgraded CME Group from a “neutral” rating to a “buy” rating and increased their price target for the company from $316.00 to $323.00 in a report on Thursday, June 11th. Raymond James Financial reaffirmed an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective on the stock in a research report on Thursday, June 18th. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and reduced their target price for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. Finally, JPMorgan Chase & Co. raised their target price on shares of CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a report on Thursday, July 23rd. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average price target of $288.56.

Get Our Latest Stock Analysis on CME

CME Group Trading Up 1.5%

CME opened at $279.17 on Tuesday. The stock has a market cap of $100.38 billion, a price-to-earnings ratio of 23.68, a P/E/G ratio of 3.27 and a beta of 0.23. The stock’s 50 day moving average price is $251.43 and its 200-day moving average price is $279.47. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the prior year, the business posted $2.96 earnings per share. The company’s revenue for the quarter was up .8% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio is 44.11%.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.